A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk.

P, Krippl; U, Langsenlehner; W, Renner; B, Yazdani-Biuki; G, Wolf; TC, Wascher; B, Paulweber; J, Haas; H, Samonigg

doi:10.1002/ijc.11238

Public

A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk.

Shared by NobleBlocks on Sep 1, 2003 • 12:00 AM UTC

Authors:

Krippl P

Langsenlehner U

Renner W

Abstract

A common 936 C/T polymorphism in the gene for the vascular endothelial growth factor (VEGF) has been associated with VEGF plasma levels. In our case-control study, we investigated the role of this polymorphism for breast cancer risk. VEGF genotype was determined in 500 women with breast cancer and 5...

Discussions